(19)
(11) EP 3 540 100 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.11.2022 Bulletin 2022/44

(45) Mention of the grant of the patent:
17.08.2022 Bulletin 2022/33

(21) Application number: 18210289.7

(22) Date of filing: 27.09.2012
(51) International Patent Classification (IPC): 
C40B 50/00(2006.01)
 C40B 40/10(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/1044; C40B 40/08; C40B 50/06

(54)

FIBRONECTIN TYPE III REPEAT BASED PROTEIN SCAFFOLDS WITH ALTERNATIVE BINDING SURFACES

AUF FIBRONEKTIN-TYP-III-REPEAT BASIERENDE PROTEINGERÜSTE MIT ALTERNATIVEN BINDUNGSOBERFLÄCHEN

ÉCHAFAUDAGE DE PROTÉINE À BASE DE RÉPÉTITION DE FIBRONECTINE DE TYPE III AVEC DES SURFACES DE LIAISON ALTERNATIVES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 27.09.2011 US 201161539670 P

(43) Date of publication of application:
18.09.2019 Bulletin 2019/38

(60) Divisional application:
22190632.4

(62) Application number of the earlier application in accordance with Art. 76 EPC:
12834641.8 / 2761066

(73) Proprietor: Janssen Biotech, Inc.
Horsham, PA 19044 (US)

(72) Inventors:
  • Diem, Michael
    Spring House, PA 19044 (US)
  • Jacobs, Steven
    Spring House, PA 19477 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A2-2010/051274
US-A1- 2005 038 229
 WO-A2-2011/137319
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).